MarjorieGlassZaudererMDMS

PubMed

• Safety and efficacy of percutaneous cryoablation for primary and metastatic pleural based tumors.
  Elena N Petre, Erica S Alexander, Michael Offin, Marjorie Zauderer, Ken Zhao, Vlasios Sotirchos, Stephen B Solomon, Etay Ziv> ;European Journal of Radiology. 2024 Apr 10
• The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK.
  Hiroki Sato, Tatsuo Ito, Takuo Hayashi, Shigehisa Kitano, Hediye Erdjument-Bromage, Matthew J Bott, Shinichi Toyooka, Marjorie Zauderer, Marc Ladanyi> ;Oncogene. 2024 Apr 1
• 1 citations
  Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
  Szlosarek, P., Creelan, B., Sarkodie, T., Nolan, L., Taylor, P., Olevsky, O., Grosso, F., Cortinovis, D., Chitnis, M., Roy, A., Gilligan, D., Kindler, H., Papadatos-Pa...> ;JAMA Oncology. 2024 Feb 15
• Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma.
  Christopher A Febres-Aldana, Jason C Chang, Achim A Jungbluth, Prasad S Adusumilli, Francis M Bodd, Denise Frosina, Jerica A Geronimo, Enmily Hernandez, Helen Irawan, ...> ;Modern Pathology. 2024 Mar 1
• 1 citations
  Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma.
  Zhang, Z., Shin, J., Offin, M., Shepherd, A., Wu, A., Shaverdian, N., Gelblum, D., Gomez, D., Sauter, J., Ginsberg, M., Adusumilli, P., Rusch, V., Zauderer, M., Rimner...> ;Radiotherapy and Oncology. 2024 Feb 1
• 1 citations
  Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment.
  Christopher A Febres-Aldana, Rachel Fanaroff, Michael Offin, Marjorie G Zauderer, Jennifer L Sauter, Soo-Ryum Yang, Marc Ladanyi> ;Annual Review of Pathology. 2024 Jan 24
• 1 citations
  Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytop...
  Yan Li, Abeer M Salama, Marina K Baine, Francis M Bodd, Michael D Offin, Natasha Rekhtman, Marjorie G Zauderer, William D Travis, Prasad S Adusumilli, Jennifer L Sauter> ;Cancer Cytopathology. 2023 Aug 1
• Short Report of a Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM).
  Antoinette J Wozniak, Bryan Schneider, Gregory P Kalemkerian, Bobby Daly, Wei Chen, Jaclyn Ventimiglia, Misako Nagasaka, Marjorie G Zauderer> ;Clinical Lung Cancer. 2023 Sep 1
• 3 citations
  Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis.
  Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y Gelblum, Raja-Elie E Abdulnour, Annemarie F Shepherd, Narek Shaverdian, Abraham J Wu, Joh...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Aug 1
• 1 citations
  Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma.
  Melina E Marmarelis, Xiao Wang, Leonid Roshkovan, Connor B Grady, John T Miura, Michelle S Ginsberg, Christine A Ciunci, Jacklynn Egger, Suzanne Walker, Andrea Cercek,...> ;JAMA Network Open. 2023 Mar 1
• Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma.
  Kevin Branch, Prasad S Adusumilli, Marjorie G Zauderer> ;Translational Lung Cancer Research. 2023 Feb 28
• Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations.
  Allison Lipitz-Snyderman, Susan Chimonas, Sham Mailankody, Michelle Kim, Nicholas Silva, Anuja Kriplani, Leonard B Saltz, Smita Sihag, Carlyn Rose Tan, Maria Widmar, M...> ;Cancer Medicine. 2023 Apr 1
• 2 citations
  Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection...
  Yan Li, Soo-Ryum Yang, Ying-Bei Chen, Prasad S Adusumilli, Ann Bialik, Francis M Bodd, Marc Ladanyi, Jessica Lopardo, Michael D Offin, Valerie W Rusch, William D Travi...> ;Modern Pathology. 2023 Mar 1
• 2 citations
  A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma.
  Andreas Rimner, Prasad S Adusumilli, Michael D Offin, Stephen B Solomon, Etay Ziv, Sara A Hayes, Michelle S Ginsberg, Jennifer L Sauter, Daphna Y Gelblum, Annemarie F ...> ;JTO Clinical and Research Reports. 2023 Jan 1
• 3 citations
  Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.
  Navin K Chintala, Jennie K Choe, Erin McGee, Rebecca Bellis, Jasmeen K Saini, Srijita Banerjee, Andre L Moreira, Marjorie G Zauderer, Prasad S Adusumilli, Valerie W Rusch> ;Frontiers in Immunology. 2023 Jan 1
• Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library.
  Michael Offin, Jennifer L Sauter, Sam E Tischfield, Jacklynn V Egger, Shweta Chavan, Nisargbhai S Shah, Parvathy Manoj, Katia Ventura, Viola Allaj, Elisa de Stanchina,...> ;Genome Medicine. 2022 Nov 15
• 39 citations
  Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
  Justin Jee, Emily S Lebow, Randy Yeh, Jeeban P Das, Azadeh Namakydoust, Paul K Paik, Jamie E Chaft, Gowtham Jayakumaran, A Rose Brannon, Ryma Benayed, Ahmet Zehir, Mar...> ;Nature Medicine. 2022 Nov 1
• 6 citations
  Multimodality Therapy in Patients With Primary Pericardial Mesothelioma.
  Michael Offin, Dilanka L De Silva, Jennifer L Sauter, Jacklynn V Egger, Ellen Yorke, Prasad S Adusumilli, Andreas Rimner, Valerie W Rusch, Marjorie G Zauderer> ;Journal of Thoracic Oncology. 2022 Dec 1
• 9 citations
  Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.
  Semanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann, Yelena Kemel, Esther Drill, Hira Rizvi, Kaitlyn Tkachuk, Aliya Khurram, Michael F Walsh, Marjorie G Zauder...> ;Cancer Epidemiology, Biomarkers & Prevention. 2022 Jul 1
• 1 citations
  Evolving Landscape of Initial Treatments for Patients with Malignant Pleural Mesotheliomas: Clinical Trials to Clinical Practice.
  Michael Offin, Valerie W Rusch, Andreas Rimner, Prasad S Adusumilli, Marjorie G Zauderer> ;The Oncologist. 2022 Aug 5
• 36 citations
  EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study.
  Marjorie G Zauderer, Peter W Szlosarek, Sylvestre Le Moulec, Sanjay Popat, Paul Taylor, David Planchard, Arnaud Scherpereel, Marianna Koczywas, Martin Forster, Robert ...> ;The Lancet. Oncology. 2022 Jun 1
• ARCS-M: forging progress from this negative trial in malignant pleural mesothelioma.
  Marjorie G Zauderer, Michael Offin> ;The Lancet. Oncology. 2022 Apr 1
• 185 citations
  Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.
  Bastien Nguyen, Christopher Fong, Anisha Luthra, Shaleigh A Smith, Renzo G DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K Chatila, Ramyasree Madupuri, Ritika Kun...> ;Cell. 2022 Feb 3
• 12 citations
  Image-guided interventional radiological delivery of chimeric antigen receptor (CAR) T cells for pleural malignancies in a phase I/II clinical trial.
  Mario Ghosn, Waseem Cheema, Amy Zhu, Jennifer Livschitz, Majid Maybody, Franz E Boas, Ernesto Santos, DaeHee Kim, Jason A Beattie, Michael Offin, Valerie W Rusch, Marj...> ;Lung Cancer. 2022 Mar 1
• 1 citations
  Treatment of Platinum Nonresponsive Metastatic Malignant Peritoneal Mesothelioma With Combination Chemoimmunotherapy.
  Michael B. Foote, Jinru Shia, Marjorie G. Zauderer, Garrett M. Nash, Andrea Cercek> ;Journal of Immunotherapy. 2021 Nov 1
• Join now to see all

Lectures

• Association of BAP1 alterations with malignant pleural mesothelioma treated with trimodality therapy. 
  2019 ASCO Annual Meeting - 6/1/2019
• Phase 2, multicenter study of the EZH2 inhibitor tazemetostat as monotherapy in adults with relapsed or refractory (R/R) malignant mesothelioma (MM) with BAP1 inactiva... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018